Biblio
Dual mechanisms by which MiR-125b represses IRF4 to induce myeloid and B cell leukemias. Blood. 2014.
Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint Inhibition. Cell. 2020.
Predicting Radiotherapy Responses and Treatment Outcomes Through Analysis of Circulating Tumor DNA. Semin Radiat Oncol. 2015;25(4):305-312.
.